These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 23781007)

  • 61. Parkinson's disease beyond 20 years.
    Cilia R; Cereda E; Klersy C; Canesi M; Zecchinelli AL; Mariani CB; Tesei S; Sacilotto G; Meucci N; Zini M; Ruffmann C; Isaias IU; Goldwurm S; Pezzoli G
    J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):849-55. PubMed ID: 25280915
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry.
    Ben-Shlomo Y; Churchyard A; Head J; Hurwitz B; Overstall P; Ockelford J; Lees AJ
    BMJ; 1998 Apr; 316(7139):1191-6. PubMed ID: 9583926
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Longitudinal study of normal cognition in Parkinson disease.
    Pigott K; Rick J; Xie SX; Hurtig H; Chen-Plotkin A; Duda JE; Morley JF; Chahine LM; Dahodwala N; Akhtar RS; Siderowf A; Trojanowski JQ; Weintraub D
    Neurology; 2015 Oct; 85(15):1276-82. PubMed ID: 26362285
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease.
    Hughes TA; Ross HF; Musa S; Bhattacherjee S; Nathan RN; Mindham RH; Spokes EG
    Neurology; 2000 Apr; 54(8):1596-602. PubMed ID: 10762499
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study).
    Reid WG; Hely MA; Morris JG; Loy C; Halliday GM
    J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):1033-7. PubMed ID: 21335570
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Changes in motor subtype and risk for incident dementia in Parkinson's disease.
    Alves G; Larsen JP; Emre M; Wentzel-Larsen T; Aarsland D
    Mov Disord; 2006 Aug; 21(8):1123-30. PubMed ID: 16637023
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical course of patients with idiopathic Parkinson's disease.
    Roos RA; Jongen JC; van der Velde EA
    Mov Disord; 1996 May; 11(3):236-42. PubMed ID: 8723138
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.
    Wang G; Huang Y; Chen W; Chen S; Wang Y; Xiao Q; Liu J; Fung VS; Halliday G; Chen S
    Parkinsonism Relat Disord; 2016 Mar; 24():89-94. PubMed ID: 26776090
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learning.
    Severson KA; Chahine LM; Smolensky LA; Dhuliawala M; Frasier M; Ng K; Ghosh S; Hu J
    Lancet Digit Health; 2021 Sep; 3(9):e555-e564. PubMed ID: 34334334
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    JAMA Neurol; 2013 May; 70(5):580-6. PubMed ID: 23529397
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson's Disease: The ICICLE-PD Study.
    Martin-Ruiz C; Williams-Gray CH; Yarnall AJ; Boucher JJ; Lawson RA; Wijeyekoon RS; Barker RA; Kolenda C; Parker C; Burn DJ; Von Zglinicki T; Saretzki G
    J Parkinsons Dis; 2020; 10(1):193-206. PubMed ID: 31868677
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Risk of dementia after Parkinson's disease in Taiwan: a population-based retrospective cohort study using National Health Insurance claims.
    Liu CC; Sun Y; Lee PC; Li CY; Hu SC
    BMJ Open; 2019 Mar; 9(3):e025274. PubMed ID: 30833322
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mortality from Parkinson's disease in China: Findings from a ten-year follow up study in Shanghai.
    Zhang Y; Wang C; Wang Y; Xiao Q; Liu J; Ma J; Zhou H; Pan J; Tan Y; Chen S; Xu G; Wang G
    Parkinsonism Relat Disord; 2018 Oct; 55():75-80. PubMed ID: 29802079
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study.
    Chen H; Kwong JC; Copes R; Tu K; Villeneuve PJ; van Donkelaar A; Hystad P; Martin RV; Murray BJ; Jessiman B; Wilton AS; Kopp A; Burnett RT
    Lancet; 2017 Feb; 389(10070):718-726. PubMed ID: 28063597
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Motor impairment in PD: relationship to incident dementia and age.
    Levy G; Tang MX; Cote LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Neurology; 2000 Aug; 55(4):539-44. PubMed ID: 10953188
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
    Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
    Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Subjective cognitive decline and progression to dementia in Parkinson's disease: a long-term follow-up study.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Neurol; 2019 Mar; 266(3):745-754. PubMed ID: 30635723
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study.
    Tan MMX; Malek N; Lawton MA; Hubbard L; Pittman AM; Joseph T; Hehir J; Swallow DMA; Grosset KA; Marrinan SL; Bajaj N; Barker RA; Burn DJ; Bresner C; Foltynie T; Hardy J; Wood N; Ben-Shlomo Y; Grosset DG; Williams NM; Morris HR
    Brain; 2019 Sep; 142(9):2828-2844. PubMed ID: 31324919
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Longitudinal outcome of Parkinson's disease patients with psychosis.
    Factor SA; Feustel PJ; Friedman JH; Comella CL; Goetz CG; Kurlan R; Parsa M; Pfeiffer R;
    Neurology; 2003 Jun; 60(11):1756-61. PubMed ID: 12796526
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
    Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
    J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.